Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Platelets Journal: Glycocalicin Accumulation Within Thrombi Reveals Species-Specific Mechanisms
Nov 21, 2026, 06:24

Platelets Journal: Glycocalicin Accumulation Within Thrombi Reveals Species-Specific Mechanisms

Platelets Journal shared a post on LinkedIn about a recent article by Caitlin Debaene et al, adding:

“Recently published in Platelets!

‘Glycocalicin is contained inside the thrombus’ by Caitlin Debaene, et al. (2026).

ADAM17 sheds GPIbα to release glycocalicin, but this process takes place over hours, and therefore, it is unknown whether this fragment is retained in a clot.

Debaene and colleagues measured glycocalicin using an in house ELISA in in vitro thrombi and an inferior vena cava (IVC) ligation model, testing ADAM17 dependence with inhibitors and platelet specific Adam17 knockout mice.

Glycocalicin accumulated inside thrombi throughout: 4.0 plus minus 0.8 vs 1.0 plus minus 0.1 µg mL in surrounding serum for human whole blood (p equal .0001), and 135.1 plus 44.3 vs 8.2 plus 1.0 µg mL after IVC ligation, with no rise in the circulation.

Notably, a species specific difference emerged with further testing.

ADAM17 inhibition halved glycocalicin in human thrombi (1.6 plus minus 0.5 to 0.8 plus minus 0.1 µg mL; p low .0001), while in mice neither inhibitors nor knockout reduced intrathrombic levels, despite that knockout dropping steady state plasma glycocalicin five fold (1.3 plus minus 0.5 vs 7.1 plus minus 2.6 µg mL).

The authors cite glycocalicin’s 7.8 nm radius against a thrombus core impermeable above 6.4 nm, and propose enzymatic redundancy in mice, ADAM10 being the candidate their inhibitors cannot exclude.”

Title: Glycocalicin is contained inside the thrombus

Authors: Caitlin Debaene, Katrijn R. Six, Sarah Vertongen, Carine De Buck, Hendrik B. FeysPlatelets Journal: Glycocalicin Accumulation Within Thrombi Reveals Species-Specific Mechanisms

Stay updated on all scientific advances with Hemostasis Today.